279 related articles for article (PubMed ID: 28455242)
1. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
2. Ras Regulates Rb via NORE1A.
Barnoud T; Donninger H; Clark GJ
J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
[TBL] [Abstract][Full Text] [Related]
3. NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.
Donninger H; Barnoud T; Clark GJ
Cell Cycle; 2016 Sep; 15(17):2263-4. PubMed ID: 26919075
[TBL] [Abstract][Full Text] [Related]
4. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
Schmidt ML; Donninger H; Clark GJ
J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
[TBL] [Abstract][Full Text] [Related]
5. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
6. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
[TBL] [Abstract][Full Text] [Related]
7. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
[TBL] [Abstract][Full Text] [Related]
8. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.
Bee C; Moshnikova A; Mellor CD; Molloy JE; Koryakina Y; Stieglitz B; Khokhlatchev A; Herrmann C
J Biol Chem; 2010 May; 285(21):16258-66. PubMed ID: 20339001
[TBL] [Abstract][Full Text] [Related]
9. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
[TBL] [Abstract][Full Text] [Related]
10. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
[TBL] [Abstract][Full Text] [Related]
11. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.
Cipriano R; Kan CE; Graham J; Danielpour D; Stampfer M; Jackson MW
Proc Natl Acad Sci U S A; 2011 May; 108(21):8668-73. PubMed ID: 21555587
[TBL] [Abstract][Full Text] [Related]
13. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.
Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
J Biol Chem; 2013 Apr; 288(16):11572-80. PubMed ID: 23443660
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
Talluri S; Francis SM; Dick FA
PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
[TBL] [Abstract][Full Text] [Related]
15. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-induced senescence pathways weave an intricate tapestry.
Yaswen P; Campisi J
Cell; 2007 Jan; 128(2):233-4. PubMed ID: 17254959
[TBL] [Abstract][Full Text] [Related]
18. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
19. PRAK is essential for ras-induced senescence and tumor suppression.
Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cancer metabolism by oncogenes and tumor suppressors.
Iurlaro R; León-Annicchiarico CL; Muñoz-Pinedo C
Methods Enzymol; 2014; 542():59-80. PubMed ID: 24862260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
